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Cysteine catabolism is dependent upon cysteine dioxygenase (CDO), a thiol dioxygenase 
encoded by the gene CDO1.  The clinical literature and, more recently, the study of CDO 
polymorphisms in disease and control populations have illustrated a strong association of 
impaired metabolism of cysteine to sulfate and taurine and/or CDO loss-of-function mutations 
with a variety of autoimmune and neurodegenerative diseases.  The Stipanuk research group has 
recently generated a germ-line CDO knockout (CDO
-/-) mouse that clearly has metabolic and 
phenotypic abnormalities.  Phenotypically, CDO knockout (null) mice exhibit signs of 
connective tissue and skeletal abnormalities, especially joint hyperlaxity (hypermobility) and 
wry nose (contortions in the nasal bone).   Our studies indicate that CDO null mice have clear 
connective tissue abnormalities.  Key abnormal features include significant increases in lung air 
space, measured by mean linear intercept; lung elastic fiber disarray and entanglement; 
significant increase in matrix metalloproteinase-12 (MMP-12), an enzyme involved in degrading 






LITERATURE REVIEW  
Cysteine Metabolism 
Cysteine is a sulfur amino acid utilized both for the synthesis of proteins and the 
synthesis of essential non-protein compounds, which include glutathione, taurine, pyruvate and 
sulfate.   Key enzymes involved in the catabolism of cysteine to the non-protein compounds 
include glutamate-cysteine ligase, cystathionine ￿-lyase, cystathionine ￿-synthase, 
cysteinesulfinate decarboxylase, and cysteine dioxygenase (CDO) (1).  The activity of most of 
these enzymes is highest in liver, the organ that plays a central role in metabolizing cysteine (2).  
The CDO pathway is the first step in the oxidative catabolism of cysteine, yielding 
cysteinesulfinate, which can be further catabolized to sulfate and pyruvate or to taurine.  In 
response to high levels of dietary protein or sulfur amino acids, hepatic CDO of mice undergoes 
up to a 30-fold change in concentration and up to 10-fold changes in catalytic efficiency, 
translating to an overall 300-fold increase in catalytic CDO activity (1,3,4,5).  This abundant 
regulation of CDO suggests that control of cysteine concentration is crucial to living organisms.   
 
CDO not only removes excess cysteine but is necessary to meet the physiological 
demands for inorganic sulfate and taurine.  High plasma cysteine levels and low plasma sulfate 
levels have been associated with severity and rapid progression of rheumatoid arthritis and with 
incidence of several neurological diseases (6). The study of CDO polymorphisms in disease and 
control populations has provided further support for a strong association of CDO genetic 
polymorphisms with rheumatoid arthritis (7).  The Stipanuk group has generated germ-line CDO 
knockout or null mice (CDO
-/-) that clearly have metabolic and phenotypic abnormalities.  
Phenotypically, CDO

































ns from the la
Diagram illustr
volved in promo
n our study, 



































ges (8).  Rele
he craniofaci
s origins from
Figure 1).   
nesis from pre-c













cursor cells.  F
et al. (8).    
he craniofaci







study is the 
has its origin



























neural tube migrate from the branchial arches and frontonasal mass (9).  These cells then make 
up the cartilage and bone of the craniofacial skeleton.  Examples of craniofacial structures that 
the neural crest cells generate include the frontal and parietal bones.  The process of neural crest 
cell differentiation into craniofacial skeletal structures depends on cytokine signaling to the 
epithelial cells.  The mesenchyme cells, which are pluripotent stem cells, receive downstream 
cytokine signals from the epithelial cells before secreting their own signals to promote the 
growth and differentiation of neural crest cells into craniofacial structures (9).   
 
Ossification in the mouse skeleton occurs between days 14 and 15 after fertilization (10,11). 
For this particular study, interest was in the skeletal features of the cranium, sternebrae, and 
femur of CDO null and wild-type (CDO
+/+) mice.  Renditions of these skeletal features are 
displayed in Figure 2.  The skull and extremities of the mouse fetus are normally fully ossified 
two days before birth (12).  Mice have six sternebrae numbered 1-6.  By convention, the 
sternebrae are labeled from the most cephalic sternebra (sternebra 1) to the most caudal sternebra 
(sternebra 6).  Most of the sternebrae are fully ossified in each of their unilateral ossification 
center at birth, but sternebra 5 tends to lag behind in becoming fully ossified.  A study found that 
in a cohort of 67 mice, all mice had fully unilaterally ossified sternebra 5 by post natal day 
(PND) 12 (12).  Since the mice used in our study were between PND 54 and PND 61, we 
assumed that all unilateral ossification centers were fully ossified.  Our focus was not on the 
unilateral fusion of a single sternebra.  Instead, our focus was on observing the fusion that joins 
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The addition of extra domains to the core domains of the MMPs characterizes the idiosyncrasies 
of each type of MMP. 
  
In addition to structural similarities, MMPs are often classified based on functional 
similarities as follows: collagenases (MMP-1,-8,-13); gelatinase (MMP-2,-9); stromelysins 
(MMP-3,-10,-11); matrilysins (MMP-7,-26); membrane-type (MT-MMP-14,-15,-16,-17,-24,-5); 
and others (MMP-12 is considered a macrophage elastase) (29).  
 
Two MMPs relevant to this study are MMP-9 and MMP-12.  Most MMPs do not have 
any one particular substrate.  Subsequently, a MMP like gelatinase (MMP-9) cleaves a variety of 
proteinaceous ECM components, including plasminogen, gelatin, elastin, and collagen (Type IV, 
V, XI and XIV) (30).  As another example, MMP-12 cleaves collagen (IV and V), gelatin, 
elastin, and fibronectin (31).  MMP-9 is produced primarily by epithelial cells and macrophages 
(32). MMP-12 is primarily produced by macrophages and targets the epithelial cells (33,34).  
Our attention to MMP-9 and MMP-12 was localized to the lungs of CDO null mice, where 
connective tissue pathology was apparent.  Imbalances in the MMPs have been recorded to result 
in lung pathology, including chronic inflammation, emphysema, and chronic obstructive 
pulmonary disease.  Specifically, lungs with an up-regulation of MMP-9 and MMP-12 have been 
accompanied by the disarray seen in emphysemic and fibrotic lungs (35,36).  Our selective 
attention to MMP-9 and MMP-12 is fitting to their role in degrading collagen and elastin, a 
normal physiological process that presented itself pathologically in histological images of our 
CDO null mice.  Equally as important as the MMPs are the TIMPs, which act antithetical to 





dependent on the up-regulation or the down-regulation of any one MMP or any one TIMP but by 
the nexus and homeostatic balances between the MMPs and TIMPs.   
Tissue Inhibitors of Matrix Metalloproteinases  
Tissue inhibitors of matrix metalloproteinases (TIMPs) are specific inhibitors of MMPs 
that control the proteolytic activity of MMPs in tissues.  TIMPs bind MMPs in a 1:1 ratio and are 
equally as important as MMPs are for development and tissue remodeling.  The stoichiometric 
ratio prevents MMPs from catalyzing excessive degradation of connective tissue proteins, while 
allowing connective tissue formation to occur.  At the time of this study, four TIMPs have been 
classified in vertebrates (TIMP-1, TIMP-2, TIMP-3, and TIMP-4) (37,38).  Like MMPs, TIMPs 
have other biological functions in addition to the MMP inhibitory function they were named 
after.  For instance, TIMP-1 and TIMP-2 have erythroid-potentiating and cell growth activity 
(39,40); TIMP-3 regulates inflammation (41); and TIMP-4 has been found to be cardio-
protective (42). In our attempts to evaluate homeostatic imbalances in MMP-9 and MMP-12, we 
used TIMP-1 and TIMP-3 for their known function to inhibit both of the MMPs under study.  
Moreover, TIMP-1 inhibits the activity of most MMPs with the exception of MT1-MMP and 
MMP-2 (43).  Thus, any dysregulation of TIMP-1 may have a broader implication than simply 
an effect on MMP-12.  TIMP-3 inhibits MMPs-1,-2,-3,-9, and -13 and was selected based on its 
anti-inflammatory functions (41,44).  Thus, if damage in the lung of our mice is due to 







Generation of mice 
 
Mice were housed in a pathogen free barrier facility.  All animals had access to an 
irradiated standard non-purified rodent diet (7012 Teklad LM-485, Harlan Laboratories, Inc.) 
(except when a non-purified diet is indicated) and water ad libitum.  Male and female mice 
heterozygous for the null CDO allele were intercrossed to generate wild-type (CDO
+/+), 
heterozygous (CDO 
+/) and null (CDO
/) mice.  Animals were genotyped at postnatal day 14 
(PND 14) and weaned at PND 28, as described previously (64).   All experimental procedures 
involving mice were approved by the Cornell University Institutional Animal Care and Use 
Committee.   
 
Morphometric analysis of skeletal structure 
 
Wild-type (WT) and null mice (n=53: 14 null females, 12 WT females, 16 null males, 11 
WT males) were euthanized by carbon dioxide inhalation when they were approximately eight 
weeks of age (ranging from 51 to 64 days of age).  Whole skeletons were prepared by the 
method of Depew (45).   Whole mice were dehydrated by incubating in 95% ethanol for two 
hours.  They were then removed from the ethanol, skinned, and eviscerated.  Muscle and 
connective tissues were left intact.  Specimens were then further incubated in 95% ethanol for 
five days, followed by incubation in acetone for six days for further dehydration and removal of 
fat.  The following cranial measurements, as suggested by Kawakami (46), were then made on 
the cranium of mice specimens using an electronic digital caliper (Fisher Scientific, PA): nasal 





width, distance between left and right anterolateral corner of the frontal bone, frontal bone width, 
and interparietal bone width.   
Skeletal staining procedure 
After documenting cranial measurements, specimens were immediately placed in a 
staining solution containing Alizarin Red (0.005%, w/v) and Alcian Blue (0.015%, w/v) dye for 
five days (46).  The mice were then transferred to a 1% (w/v) KOH solution.  The KOH solution 
was renewed three times over the course of six days in order to remove excess staining, soften 
the skeletal structure, and remove non-skeletal structures like muscles and adipose tissue.  This 
was followed by the sequential replacement of KOH with glycerol over the course of two weeks.  
Glycerol-1% (w/v) KOH solutions with decreasing ratios of glycerol-to-KOH replaced older 
solutions:  the ratio of glycerol-to-1% KOH that was added over the course of two weeks was as 
follows: 1:4, 1:1, 4:1, and finally 100% glycerol.  This procedure resulted in clearly visible 
stained bone and cartilage.  Specimens were then stored in 50-mL conical tubes containing 
glycerol until observations were made.  
 
Histomorphometric evaluation of differentially stained lung sections 
 
CDO null and wild-type animals were anesthetized by intraperitoneal injection of 
Avertin® (tribromomethanol).  Next, a scalpel blade was used to open the abdominal cavity and 
cut the diaphragm, and lungs were perfused intratracheally with a blunt butterfly catheter 
connected to a column of 4% (v/v) paraformaldehyde suspended 25 cm above the dissecting 
surface.  When the lungs were fully inflated with paraformaldehyde, the trachea was clamped, 
and the entire mass of thoracic viscera was removed intact and placed in 4% paraformaldehyde 





histological processing (Electron Microscopy and Histology Core Facility, Cornell University).  
Semi-serial, 5-µM sections from paraffin embedded tissues were processed with Verhoeff 
VanGeison (VVG), Hematoxylin and Eosin (H&E) stains to visualize and compare connective 
tissue components.  Stained sections were analyzed using an Olympus BX50 microscope with a 
Moticam 2300 cMOS camera (Motic North America, Richmond, BC).   Images from the 
Moticam 2300 cMOS camera were analyzed at 200x magnification using JMicroVision 1.2.7 
(http://www.jmicrovision.com) to evaluate mean linear intercept (MLI), a measure of the 
distance between interalveolar walls, by the method of Dunnill (47) with modifications by 
Hamelet et al. (48).  A large MLI indicates airspace enlargement in the alveoli and consequently 
reduced surface area for gas exchange.   In brief, the mean linear intercept value was calculated 
by obtaining an average of 5-9 images from lung specimens prepared for each mouse at 200x 
magnification.  Images were overlaid with a scaled 50-µM grid (approximately 10 vertical lines 
x 10 horizontal lines).  A sum of the number of alveolar walls intersected by lines in both the 
horizontal and vertical direction was divided by the total length of the lines on each image, 
yielding the MLI value.  A representative MLI for each animal was determined by averaging the 
MLI values over all images counted for that animal.   
 
 
Analysis of MMP-9, MMP-12, TIMP-1, and TIMP-3 expression by Western blotting and 
real time quantitative RT-PCR (qRT-PCR) 
 
For collection of tissues for analysis of expression of matrix metalloproteinases (MMPs) 
and tissue inhibitors of metalloproteinases (TIMPs), null and wild-type mice were both placed on 
a semi-purified rodent diet at weaning and then switched to a diet with a slightly excess level of 
sulfur amino acids at 6-7 weeks of age.  These semi-purified diets were  based on the AIN93G 
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MN), rabbit anti-mouse MMP-12 antibody (Origene, MD), rabbit anti-mouse TIMP-1 antibody 
(Origene, MD), rabbit anti-mouse TIMP-3 antibody (Abcam, Cambridge, MA), and mouse anti-
mouse Actin antibody (Cell Signaling Technology, MA).  After incubating with primary 
antibodies, the membranes were incubated with secondary complementary antibody for one 
hour.  The secondary antibodies were infrared fluorescent dye-labeled anti-mouse, anti-goat, or 
anti-rabbit IgG antibodies (IRDye, LI-COR Biosciences).  Scanning of membranes was in 
accordance with the manufacturer and the Odyssey direct infrared imaging system (LI-COR 
Bioscience).  The intensity of signals was quantified with Odyssey software (LI-COR 
Biosciences).  Results for MMPs and TIMPs were normalized for actin levels. 
  
Real time quantitative RT-PCR (qRT-PCR) measurements were performed to quantify 
MMP-9, MMP-12, TIMP-1, and TIMP-3 mRNA levels in the lung tissue samples (n=6: 3 null 
males, 3 WT males). RNA was isolated using Qiazol and RNeasy Mini Kit with on-column 
DNAse digest (Qiagen, CA). Concentration of isolated RNA was determined using a NanoDrop 
spectrophotometer (Thermo Scientific, DE), and 1 μg RNA was reverse transcribed into cDNA 
using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CA) according 
to manufacturer directions.  qRT-PCR was performed with a 480 LightCycler PCR System 
(Roche Applied Science, IN) using Sybr Green Master Mix (Applied Biosystems, CA). Actin 
was used as the endogenous (housekeeping) control.  
 
Primers were generated by Integrated DNA Technologies (IDT, IA) for target gene 
MMP-9 (forward primer, AGACGACATAGACGGCATCC; reverse primer, 





TTGTGGATAAACACTACTGGAGGT; reverse primer, AAATCAGCTTGGGGTAAGCA), 
target gene TIMP-1 (forward primer, GCAAAGAGCTTTCTCAAAGACC; reverse primer, 
AGGGATAGATAAAGAGGGAAACAC), and target gene TIMP-3 (forward primer, 
TGTCGTGCTCCTGAGCTG; reverse primer, GCTTCTTTCCCACCACTTTG. 
 
The average crosspoint (Ct) for each transcript of the target gene and for the standard 
actin gene were calculated via the LightCycler software (Roche Applied Science, IN). Average 
actin Ct values were subtracted from the average target values for each animal, yielding ΔCt.  
Next, ΔΔCt was calculated by subtracting the average WT ΔCt from each animal’s ΔCt 
value.  Fold-change was then calculated (2
-ΔΔCt).  Average values for fold-change were than 
calculated.  Calculations suggested by Pfaffl (49). 
 
Statistical Analysis 
Graph Pad Prism 4 Software – Data were analyzed with unpaired one-tail t-test values for 
cranial measurements, MLI measurements, and quantitative Western blotting measurements 
between CDO null and wild-type mice.  The significance of effects of genotype and sex (and 
there interaction) on the incidence of abnormal bone features in the sternebrae, nasal bone, and 
xiphoid cartilage was assessed by a logistic regression (JMP Statistical Software).  Fisher’s exact 
two-tail test was also used to analyze significance of male and female effects on abnormal 








Four cranial landmark measurements highlight bone growth stunting  
Lengths of the following cranial landmarks were quantified for all specimens (n=53; 14 
CDO null females, 12 wild-type females, 16 CDO null males, 11 wild-type males): nasal bone 
length (NL), frontal bone length (FL), parietal bone length (PL), interparietal bone length (IL), 
nasal bone width (NW), left and right corner of frontal bone (LR), frontal bone width (FW), and 
interparietal bone width (IW).  Figure 5 illustrates the various bone lengths and widths measured.  
A statistically significant difference in four landmarks of cranium size was seen in CDO null 
mice compared with wild-type mice.  The four landmarks were the NL (females, p=0.032; males, 
p=NS), FL (female, p=0.035; male, p=0.016), NW (female, p=0.030; male, p=0.002), and LR 
(female, p=NS; male, p=0.002) (Figure 6).  In null mice of both sexes, FL was significantly less 
and NW was significantly greater.  On the other hand, NL was significantly less only in CDO 
null female mice, and LR was significantly less only in CDO null male mice compared to wild-





















































Figure 6. Graphical representation of landmark measurements of the cranium.  Measurements with statistical 
significance were noted.  Asterisks indicate p < 0.050.  Mean data are indicated above each bar ± standard error of 
mean (SEM). N=53: 14 CDO null females, 12 WT females, 16 CDO null males, 11 WT males. 
  
* *





Skeletal staining identified abnormal formation of bone and poor ossification 
 
Three notable skeletal abnormalities were noted in CDO null mice compared to wild-type 
mice.  These differences are embodied in the nasal bone, sternebrae, and xiphoid cartilage.   
 
The nasal bone of CDO null mice was typically observed to be contorted (Figure 7a).  
None of the male wild-type mice were seen to have the contorted nasal bone, whereas 38% of the 
male CDO null mice exhibited the contorted nasal bone (Figure 8).  Female mice had slightly 
different outcomes; 17% of wild-type female mice and 36% of CDO null female mice were 
observed to exhibit the contorted nasal bone (Figure 8).  A nominal likelihood ratio χ
2 test 
obtained from logistic regression (Table 1) confirmed significant increases (p=0.013) in the 
contorted nasal bone among all CDO null mice.  No statistical significance was seen between the 
sex of the mice and the frequency of the contortion.    This analysis also showed no significant 
interaction between sex and genotype. 
 
Wild-type mice are more inclined to have a fusion between sternebrae 4 and 5 (Figure 7d, 
red arrows), whereas CDO null mice frequently had a separation between sternebrae 4 and 5 
(Figure 7d, arrows).  None of the male and female wild-type mice lacked fusion between 
sternebra 4 and sternebra 5 (Figure 8).  In contrast, 87% and 43% of the male and female CDO 
null specimens, respectively, lacked fusion between sternebra 4 and sternebra 5 (Figure 8).  
Likelihood ratio χ
2 test obtained from logistical regression (Table 1) confirmed significant 
dependence of frequency of fusion on the genotype (p<0.0001) and on sex (p=0.008).  This 
analysis also showed no significant interaction between sex and genotype.  Two-tail Fisher’s 






The xiphoid cartilage is the cartilaginous extension below sternebra 6 (Figure 7d, orange 
arrow).  In this study, 9% of the male and 42% of the female wild-type mice had a medially 
unfused xiphoid cartilage, whereas 69% (male) and 86% (female) of CDO null mice had a 
medially unfused xiphoid cartilage (Figure 8).  Likelihood ratio χ
2 test obtained from logistical 
regression (Table 1) confirmed significant dependence of frequency of fusion on the genotype 
(p<0.0001) and on sex (p=0.040).  This analysis also showed no significant interaction between 
sex and genotype.  Two-tail Fisher’s exact test on male and female sex effect on xiphoid 
cartilage fusion showed similar results (data not included).  
 
A typical newborn mouse should have fully ossified skull, axial skeleton, and limb by the 
end of gestation, with the exception of the phalanx (12).  In our skeletal staining study, the paired 
use of both Alizarin Red and Alcian Blue allowed for the identification of both ossified areas of 
bone and collagen-rich areas; the Alizarin Red dye was used to stain ossified bone red, whereas 
the Alcian Blue dye was used to stain collagen blue.  Since a violet color designates an 
intermediate between blue and red, violet-colored femora of CDO null mice indicated poor 
ossification in null mice compared with wild-type mice (Figure 7b).  The epiphyseal plate of the 
femur also demonstrated some of the same characteristics with differential staining (Figure 7c); 
the bluer staining in CDO null mice within the epiphyseal plate indicates incomplete ossification 
of the epiphyseal plate.  No quantitative data on abnormal features of the femora were obtained.   
In contrast to skeletal staining outcomes, bone density evaluations through x-ray and DEXA 
scanning showed no conclusive evidence of bone density differences between wild-type
 and   
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  Sex  No. of Contorted 
(Wry) Nasal Bone 
No. of Unfused 
Sternebra 4 with 
Sternebra 5 




M 0    0  1 
F 2  0  5 
M+F 2  0  6 
 
CDO Null 
M 6  4  11 
F 5  6  12 
M+F 11  10  23 
 
Effect  
G (p=0.013);  
S (p=NS);  
SxG (p=NS) 
G (p<0.0001);  
S (p=0.008);  
SxG (p=NS)
G (p<0.0001);  
S (p=0.040);  
SxG (p=NS)
 
Table 1. Number of specimens with specified traits according to sex (M=male, F=female) and genotype.  Nominal 
likelihood ratio χ
2 test was used for statistical analysis of dependence of genotype (G), sex (S), and the interaction 
between sex and genotype (SxG), on phenotype outcomes.  Probability of the ratio not being different from 1.0 are 
indicated as NS (non-significant = p > 0.050).   
 
CDO null mice have significant alveolar airspace enlargement 
Representative histological images of wild-type and CDO null lung stained with H&E are 
shown in Figure 9.  Analysis of differentially stained lung sections of 8-week old CDO null mice 
showed enlarged alveolar airspaces. The mean linear intercept (MLI) for wild-type and/or CDO 
heterozygous (n=10: 4 females, 6 males) and CDO null (n=9: 4 females, 5 males) animals was 
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Histological staining reveals elastin breakage 
Using VVG staining procedures (Figure 11a-d, f), in which collagen stains red and elastic 
fibers (and nuclei) stain black, our histological images illustrate abnormalities in lungs of CDO 
null mice.   Intima (posterior to the luminal endothelial cells) of both intra-acinar pulmonary 
vessels (Figure 11c) and larger pre-acinar pulmonary vessels (Figure 11b right) demonstrate 
thickened, fragmented and disorganized elastic fibers in CDO null mice.  Fragmentation and 
tangled disarray of elastic fibers can be seen throughout the lung parenchyma in CDO null mice 
(Figure 11d).  VVG staining revealed that the red scuff posterior to the elastic fibers is primarily 
composed of collagen.  CDO null mice have strands of collagen that are thinner in shape 
compared to wild-type mice (Figure 11a and 11b).  Figure 11e displays an image stained with 
H&E in order to show endothelial cells lining the tunica intima of blood vessels.  Endothelial 
cells of the blood vessels are identified by the black-stained nuclei (Figure 11e, arrow).  In 
comparison, Figure 11f is a histological image stained with VVG.  VVG stains both nuclei and 
elastic fibers black (Figure 11f, arrow).  
 
Further testing with Western blotting confirmed higher levels of MMP-12 (elastase; 
Figure 12a) in CDO null mice.  Quantification demonstrated significantly higher levels of MMP-
12 (one-tailed t-test; p=0.009; n=6: 3 CDO null males, 3 WT males) in male CDO null mice 
compared with male wild-type mice (Figure 13a).  However, relative levels of MMP-9 
(gelatinase) were inconclusive due to non-specific binding of MMP-9 antibodies to actin 
(Western blot data not included).  Tissue inhibitors of matrix metalloproteinases (TIMPs) were 
also blotted (Figure 12b and 12c).  Quantification (Figure 13b and 13c) revealed that neither 





mice (one-tailed t-test; p=0.080 and p=0.067, respectively).  On average, however, TIMP-1 
protein levels tended to be higher in CDO null male mice, and TIMP-3 protein levels tended to 
be lower in CDO null male mice (Figure 13b and 13c).  Quantitative real time RT-PCR indicated 
that the MMP-12 mRNA was the only mRNA (out of MMP-9, TIMP-1, and TIMP-3) to have a 
large mean fold-increase of 3.22 (Table 2).  However, the standard deviation for the MMP-12 
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  Cranial measurements indicated that NL and FL were significantly shorter in CDO null 
mice (except the NL of male CDO null mice) compared with wild-type mice.  In contrast, NW 
and LR were significantly wider in CDO null mice (except the LR of female CDO null mice) 
compared to wild-type mice.  Perhaps compensatory mechanisms are in play that widen one 
structure when another structure is shortened and vice-versa.   
 
Because CDO null mice exhibited distinct nasal/cranial abnormalities and were growth-
delayed (64), a close examination of skeletal structure of mice was performed.  Several 
phenotypic differences were observed in the skeletal structure of CDO null and wild-type control 
mice.   Bone growth delay, contorted nasal bone, bone fusion abnormalities, and abnormal 
ossification were observed in CDO null mice compared to wild-type mice.  One abnormality was 
only observed in null mice and was highly predictive of null status; unfused sternebrae 4 and 5 
was observed in 33% of null mice but in none of the 23 wild-type mice.  In addition, the 
presence of a contorted nasal bone and of a medially unfused xiphoid cartilage was significantly 
more frequently observed in null mice.  A wry nasal bone was observed in 37% of null mice but 
in only 9% of wild-type mice, whereas an unfused xiphoid cartilage was observed in 77% of null 
mice but in only 26% of wild-type mice.   The delay in fusion of sternebra 4 to sternebra 5 was 
the most remarkable observation in the CDO null mice, but still not all CDO null mice had 
unfused sternebrae 4 and 5 between post natal day 51 and 64.    
 
  Interpretations of the stained femur and epiphyseal plate are limited.  Differences in body 





particular bone in specimens stained.  These same differences may have also affected how well a 
particular mouse de-stained.  In general, wild-type mice were “heavier” than CDO null mice, and 
with heavier mice, there are more skeletal muscle and adipose tissue that have to be overcome by 
staining and de-staining.  Since all specimens were stained the same number of days, differences 
in staining in the femur and epiphyseal plate may be attributed to phenotypic differences (i.e. 
body composition) between CDO null and wild-type control mice. 
 
   Due to differences in gross appearance of skeletal structures, such as the ribs, and the 
preliminary observation of lower density of whole CDO null mice when analyzed by DEXA, 
bone mineral density determinations were made on the skeleton.  DEXA scanning of the 
skeletons revealed no particular differences in bone mineral densities between CDO null and 
wild-type control mice.  In addition, x-ray imaging results culminated in ambiguous results, with 
some CDO null mice displaying prominent hollowness in the femur and with others displaying 
no differences when compared to wild-type mice.  One potential error in carrying out the DEXA 
scanning was the incomplete thawing of all mice specimens, which would have skewed density 
readings, as the lower densities associated with particulates of ice crystals would also lower the 
bone mineral density readings by the DEXA in non-thawed mice.  An error that occurred with 
the x-ray scanning was the use of non-standardized film development.  Without any calibration, 
our x-ray images did not differentiate between null and wild-type CDO mice.  These studies 
would need to be repeated to make any firm conclusions. 
 
  Logically, interests in connective tissue abnormalities extended to interests into other 





only is the lung readily assessable, but it is also primarily composed of connective tissues like 
collagen and elastin.  Initial histological staining of the lungs revealed larger air space volume, as 
indicated by significant increases in MLI, and abnormal elastin structure throughout the lung of 
CDO null mice.   
 
  Our initial hypothesis that matrix metalloproteinase enzymes may be associated with 
these observations was confirmed by the observations that elastase (MMP-12) was selectively 
up-regulated in lung of CDO null mice.  In contrast, expression of gelatinase (MMP-9), TIMP-1, 
and TIMP-3 were not significantly affected by genotype.  Western blotting confirmed that MMP-
12 protein was significantly increased in null mice, as was the trend for MMP-12 mRNA.  An 
obvious limitation in the immunoblotting study was the use of only male specimens.  In addition, 
although immunoblotting allowed quantification of the abundance of MMPs and TIMPs, 
definitive confirmation of localized increases in MMPs using immunohistochemical procedures 
would be valuable in future studies.   
 
  The relations of these phenotypic differences in CDO null mice are presumably related in 
some way to the metabolic phenotype generated by loss of CDO, a key enzyme in the oxidative 
metabolism of cysteine to its end products, taurine and sulfate.  CDO null mice have been 
characterized to have extremely low plasma and tissue taurine levels, along with slightly elevated 
plasma and tissue cysteine levels, supporting the predictive effects of lacking cysteine flux 
through the CDO metabolic pathway (64).  Taurine supplementation in CDO null mice improved 
survival of male pups with no effect on the phenotype of CDO null mice.   Speculations of 





when plasma sulfate (downstream product of cysteine catabolism) and sulfide were found to be 
slightly elevated in CDO null mice compared with wild-type mice.   Sulfide is a product of 
cysteine catabolism through the cystathionine β-synthase and cystathionine γ-lyase 
desulfhydration pathways.  Hydrogen sulfide (H2S) has dual roles as a signaling molecule and as 
a toxicant.  Thus, pathology seen in connective tissue of CDO null mice may be associated with 
dysregulation of H2S.  Yet studies have implicated beneficial effects of H2S.  H2S use has been 
suggested as a therapeutic agent for lung injury (50).  Whether or not H2S affects skeletal 
structures is not known.   
 
CDO null mice also have decreased levels of hepatic cytochrome c oxidase, an enzyme 
involved in the electron transport chain (64).  Compounding lower levels of hepatic cytochrome 
c oxidase in CDO null mice is the inhibitory effects of H2S on cytochrome c oxidase (51).  
Altogether, this suggests a possible effect of the alteration in the electron transport system of 
CDO null mice on its phenotype.        
 
A hypothesized link between loss-of-function mutations in CDO and the incidence of 
rheumatoid arthritis has existed for several decades and was largely based on observed increases 
in the cysteine-to-sulfate ratio in the plasma and low levels of sulfate in synovial fluid of patients 
with this disease (52).  High plasma cysteine-to-plasma inorganic sulfate ratios were presumed to 
alter sulfate conjugation reactions, providing a clear link to the highly sulfated proteoglycans in 
the extracellular matrix or connective tissues (52,55,56). The observations on the CDO null 
mouse, however, suggest that loss-of-function mutations of CDO do not cause a depletion of 





the greater accumulation of cysteine than of sulfate, whereas the cysteine to taurine ratios were 
dramatically higher in null mice and would seem to be a much better indicator of lack of CDO 
activity.  In addition, damage observed in CDO null mice could be associated with the increased 
production of H2S and other reduced sulfur compounds (e.g., persulfides) due to the block in the 
conversion of cysteine to cysteinesulfinate and cysteinesulfinate’s further metabolism to 
hypotaurine/taurine and sulfite/sulfate.     
 
  Other studies have found that cysteine drives the synthesis of pro-inflammatory 
leukotriene-cysteinyl adducts, which have a function in the proliferation and contraction of 
smooth muscle cells in the lung, migration of eosinophils, and damage to the mucus layer of the 
lung (57,58,59).  Recruitment of eosinophils to the lung, along with their activation, releases 
effector inflammatory cytokines and growth factors like interleukin-1 (IL-1), tumor necrosis 
factor- α (TNF-α), transforming growth factor- β (TGF-β), and vascular endothelial growth 
factor (VEGF).  These effector molecules have been demonstrated to up-regulate the 
transcription of MMP-12 (60,61).  Since the predictive effect of up-regulating the transcription 
of MMP-12 is the increase in elastin breakdown, the up-regulation of MMP-12 transcription may 
explain the pathology seen in our CDO null mice.  During inflammatory responses, H2S has been 
suggested to play a role in recruiting neutrophils (62).  Increases in MMP-12 in our lung 
specimens may be a result of increased neutrophil accumulation in CDO null mice since 
neutrophils secrete MMP-12 upon activation.  Moreover, the pathology of the lungs of CDO null 






Inspiratory resistive breathing patterns up-regulate cytokine production of interleukin-6 
(IL-6), TNF-α, and interleukin-2 (IL-2) in the diaphragm (63). Abnormal lung histology of the 
CDO null mice suggests an impaired ability to breathe in these same mice, which may perpetuate 
the pathology of CDO null mice lung; inflammatory cytokines induced upon resistive breathing 
up-regulate the expression of MMP-12, which may result in the disarray seen in CDO null mice 
lung histology.  Further work may be conducted to understand the connection between resistive 
breathing pattern and the pathology of the CDO null mouse.   
 
To better understand the connection between CDO null mice and connective tissue 
pathology, work on establishing the function of impairments in the CDO catabolic pathway on 
skeletal development should also be conducted.  Furthermore, investigating how abnormal 
taurine, cysteine, and sulfide levels in CDO null mice are associated with the inflammatory up-
regulation of MMPs would highlight key cytokines responsible for MMP up-regulation in CDO 
null mice.  This study only investigated two select MMP proteins out of the 25 or more MMPs 
that are known to exist.  Similarly, only two of the four TIMPs were studied.  Other venues of 
interest should be directed towards the investigation of which MMPs and TIMPS have prominent 









1.  Stipanuk, MH. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia: W.B. Saunders 
Co., 2000. pp. 395-398.  
2.  Bella DL, Stipanuk MH (1995) Effects of protein, methionine, or chloride on acid-base balance and on 
cysteine catabolism. Am J Physiol 269: E910–E917. 
3.  Bella DL, Hahn C, Stipanuk MH (1999) Effects of nonsulfur and sulfur amino acids on the regulation of 
hepatic enzymes of cysteine metabolism.  Am J Physiol 277: E144-153.  
4.  Lee JI, Londono M, Hirschberger LL, Stipanuk MH (2004) Regulation of cysteine dioxygenase and 
gamma-glutamylcysteine synthetase is associated with hepatic cysteine level.  J Nutr Biochem 15: 112-122. 
5.  Stipanuk MH, Londono M, Lee JI, Hu M, Yu AF (2002) Enzymes and metabolites of cysteine metabolism 
in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels.  J 
Nutr 132: 3369-3378. 
6.  Davies MH, Ngong JM, Pean A, Vickers CR, Waring RH, Elias E (1995) Sulphoxidation and sulphation 
capacity in patients with primary biliary cirrhosis. J Hepatol 22: 551–60. 
7.  Waring RH, Ramsden DB, Wilkinson LJ, and Kikuchi H (2007) Polymorphism in Cysteine Dioxygenase. 
International Publication Number WP 2007/010258 A2. World Intellectual Property Organization.  
8.  Olsen BR, Reginato AM, Wang W (2000) Bone development. Annu Rev Cell Dev Biol 16: 191–220.   
9.  Langille RM (1994) Chondrogenic differentiation in cultures of embryonic rat mesenchyme. Microsc Res 
Tech 28: 455-469. 
10.  Chen JM (1952) Studies on the morphogenesis of the mouse sternum. I. Normal embryonic development.  J 
Anat 86: 373-386. 
11.  Otis EM, Brent R (1954) Equivalent ages in mouse and human embryos.  Anat Rec 120: 33-53. 
12.  Fritz H, Hess R (1970) Ossification of the rat and mouse skeleton in the perinatal period. Teratology 3: 
331-338. 
13.  Cormack, David H. Ham’s Histology, 9
th ed. Philadelphia: J.B. Lippincott Company. 1987. pp. 551-562. 
14.  Di Fiore, Mariano S.H, Eroschenko, Victor, Ed. Atlas of Normal Histology, 6
th ed. Philadelphia: Lea & 
Febiger. 1988. p. 86. 
15.  Chin JR, Werb Z (1997) Matrix metalloproteinases regulate morphogenesis, migration and remodeling of 
epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 124:1519–30. 
16.  Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J, Kähäri 
V-M (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and 
osteoblasts during human fetal bone development. Dev Dyn 208: 387-397. 
17.  Shapiro SD (1998) Matrix metalloproteinase degradation of extracellular matrix: biological 
consequences. Curr Opin Cell Biol 10: 602-608. 
18.  Abdallah MA, Nakajima ST, Lin PC, Gercel-Taylor C (2005) Plasma matrix metalloproteinase activity 
during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation. Fertil Steril 84: 
1766–1767. 
19.  Rundhaug JE (2003) The biology behind matrix metalloproteinases, angiogenesis and cancer. Clin Cancer 
Res 9: 551-554.  
20.  Lorente L, Martin MM, Sole-Violan J, Blanquer J, Paramo JA (2010) Matrix metalloproteinases and their 
inhibitors as biomarkers of severity in sepsis. Crit Care 14: 402. 
21.  Vincenti MP, Brinckerhoff CE (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes 
in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription 
factors.  Arthritis Res 4: 157–164. 
22.  Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nature 
Rev Cancer 2: 161-174. 
23.  Van Lint P, Libert C (2007) Chemokine and cytokine processing by matrix metalloproteinases and its 
effect on leukocyte migration and inflammation. J Leukoc Biol 82 (6): 1375–81.   
24.  Nyormoi O, Mills L, Bar-Eli M (2003) An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by 
ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ 10: 558–569. 
25.  Pei D (2005) Matrix metalloproteinases target protease-activated receptors on the tumor cell 
surface. Cancer Cell 7: 207–208. 
26.  Everts V, Delaisse JM, Korper W, Beertsen W (1998) Cysteine proteinases and matrix metalloproteinases 





27.  Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL (1997) Initiation of osteoclast bone 
resorption by interstitial collagenase. J Biol Chem 272:22053–8. 
28.  Sternlicht M D, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell 
Dev. Biol. 17, 463–516. 
29.  Snoek-van Beurden PA, Von den Hoff JW (2005) Zymographic techniques for the analysis of matrix 
metalloproteinases and their inhibitors. Biotechniques 38:73– 83. 
30.  Vu TH, Z Werb (1998) Gelatinase B: structure, regulation, and function. In: Biology of Extracellular 
Matrix-Matrix Metalloproteinases. William C. Parks and Robert P. Mecham, eds., San Diego: Academic 
Press. 1998. pp. 115-148. 
31.  Tschesche H, Knäuper V, Kramer S, Michaelis J, Oberhoff R, Reinke H (1992) Latent collagenase and 
gelatinase from human neutrophils and their activation. Matrix Suppl 1: 245–255.  
32.  Ståhle-Bäckdahl M, Parks W C (1993) 92-kDa gelatinase is actively expressed by eosinophils and stored 
by neutrophils in squamous cell carcinoma. Am J Pathol 142: 995–1000.  
33.  Vaalamo M, Kariniemi AL, Shapiro SD, Saarialho-Kere U (1999) Enhanced expression of human 
metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration  J Invest Dermatol 112: 
499–505. 
34.  Nénan S, Boichot E, Lagente V, Bertrand CP (2005) Macrophage elastase (MMP-12): a pro-inflammatory 
mediator? Mem Inst Oswaldo Cruz 100(Suppl 1): 167 – 172. 
35.  Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whitsett JA 
(2000) Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D 
gene-inactivated mice. Proc Natl Acad Sci USA 97:5972–5977. 
36.  Tetley TD (2002) Macrophages and the pathogenesis of COPD. Chest 121: 156S-159S.  
37.  Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure 
and function. Biochim Biophys Acta 1477:267–283.  
38.  Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, 
function, and biochemistry. Circ Res 92:827–839.  
39.  Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA,  
Leary AC, Brown EL (1985) Molecular characterization and expression of the gene encoding human 
erythroid-potentiating activity. Nature 315: 768–771.  
40.  Stetler-Stevenson WG, Bersch N, Golde DW (1992) Tissue inhibitor of metalloproteinase-2 (TIMP-2) has 
erythroid-potentiating activity. FEBS Lett 296: 231–234. 
41.  Black RA (2004) TIMP3 checks inflammation. Nature Genet 36: 934–935. 
42.  Vacek TP, Gillespie W, Tyaqi N, Vacek JC, Tyaqi SC (2010) Hydrogen sulfide protects against vascular 
remodeling from endothelial damage.  Amino Acids 39 (5): 1161-9.  
43.  Knäuper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G (1996) 
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-
14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271: 17124–17131. 
44.  Apte SS, Olsen BR, Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-
3 and its inhibitory activities deﬁne the distinct TIMP gene family. JBiol Chem 270: 14313–14318. 
45.  Depew MJ (2008) Analysis of skeletal ontogenesis through differential staining of bone and cartilage. 
Methods Mol Biol 461: 37-45. 
46.  Kawakami M, Yamamura K-I (2008) Cranial bone morphometric study among mouse strains.  BMC 
Evolutionary Biology 8: 73. 
47.  Dunnill MS (1962) Quantitative Methods in the Study of Pulmonary Pathology. Thorax 17: 320-328. 
48.  Hamelet J, Maurin N, Fulchiron R, Delabar JM, Jane N (2007) Mice lacking cystathionine beta synthase 
have lung fibrosis and air space enlargement.  Experimental and Molecular Pathology 83: 249-253. 
49.  Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic 
Acids Res 20: 2002-2007.  
50.  Esechie A, Kiss L, Olah G, Horvath EM, Hawkins H, Szabó C, Traber DL (2008)  Protective effect of 
hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. 
Clin Sci (Lond) 115: 91-97. 
51.  Dorman DC, Moulin FJ-M, McManus BE, Mahle KC, James RA, Struve MF (2002) Cytochrome oxidase 
inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the 





52.  Bradley H, Gough A, Sokhi RS, Hassell A, Waring R, Emery P (1994) Sulfate metabolism is abnormal in 
patients with rheumatoid arthritis: confirmation by in vivo biochemical findings. J. Rheumatol 21:1192-96.  
53.  Miklos S (1995) Dehydroepiandrosterone sulfate in the diagnosis of osteoporosis. Acta BioMedica de 
L’ateneo Parmense 66: 139–146. 
54.  Parker LN (1991) Control of adrenal androgen secretion. Endocrinol Metab Clin North Am 20: 401-421. 
55.  Heaﬁeld MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG (1990) Plasma cysteineand 
sulphate levels in patients with motor neurone, Parkinson’s and Alzheimer’s disease. Neurosci Lett 110: 
216–20. 
56.  Scadding GK, Ayesh R, Brostoff J, Mitchell SC, Waring RH, Smith RL (1988) Poor sulphoxidation ability 
in patients with food sensitivity Br Med J 297: 105–7. 
57.  Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ (2002) Increased leukotrienes in 
exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 166(10): 1345–9. 
58.  Obshima N, Nagase H, Koshino T et al (2002) A functional study on CysLT(1) receptors in human 
eosinophils. Int Arch Allergy Immunol 129(1): 67–75. 
59.  Arango P, Borish L, Frierson HF Jr, Kountakis SE (2002) Cysteinyl leukotrienes in chronic hyperplastic 
rhinosinusitis. Otolaryngol Head Neck Surg 127(6): 512–15. 
60.  Kerkela E, Bohling T, Herva R, Uria JA, Saarialho-Kere U (2001) Human macrophage metalloelastase 
(MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation. 
Bone 29: 487–93. 
61.  Feinberg MW, Jain MK, Werner F, et al (2000) Transforming growth factor-beta 1 inhibits cytokine-
mediated induction of human metalloelastase in macrophages. J Biol Chem 275: 25 766–25 773. 
62.  Dal-Secco D, Cunha TM, Freitas A, Alves-Filho JC, Souto FO, Fukada SY, Grespan R, Alencar NM, Neto 
AF, Rossi MA, Ferreira SH, Hothersall JS, Cunha FQ (2008) Hydrogen sulfide augments neutrophil 
migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: 
role of ATP-sensitive potassium channels. J Immunol 181: 4287-4298. 
63.  Vassilakopoulos T, Katsaounou P, Karatza MH, Kollintza A, Zakynthinos S, Roussos C (2002) Strenuous 
resistive breathing induces plasma cytokines: role of antioxidants and monocytes.  Am J Respir Crit Care 
Med 166:1572–1578. 
64.  Ueki I,  Roman HB, Valli A, Fieselmann K, Lam J, Peters R, Hirschberger LL, and Stipanuk MH. 
 
Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize 
taurine and an increased catabolism of cysteine to hydrogen sulfide.  Am J Physiol Endocrinol Metab, in 
press. 
 
 